Clinical Trial

Optimal Radiotherapy - Heel Spur Syndrome - Randomized Clinical Trial

Study acronym: ORHEELS
Recruiting
View on ClinicalTrials.gov →
Summary
Heel Spur Syndrome (HSS), is a pathology characterized by chronic inflammation and degenerative changes that affect approximately 10% of adults. Although many patients respond to conservative care, about 30% experience persistent pain. Low-dose radiation therapy (LDRT) is a well-established European method with proven anti-inflammatory and immunomodulatory effects. The ORHEELS trial aims to assess whether a Polish standard dose of 6 Gy in 6 daily fractions (fx)(5 times/week) is not inferior to the treatment with total dose of 3 Gy / fx 0,5 Gy /fractionated twice weekly. The study is designed to assess the impact of intensity of treatment (daily (5 times / week) versus twice weekly fractionation) on clinical outcomes.
Trial Details
NCT Number NCT07546240
Lead Sponsor Maria Sklodowska-Curie National Research Institute of Oncology
Conditions Heel Spur Syndrome
Enrollment 366 participants
Start Date 2026-03-23
Primary Completion 2030-03-22 (estimated)
Study Completion 2030-03-22 (estimated)
Updated on ClinicalTrials.gov 2026-04-22